Zimmer Biomet Holdings (ZBH) has been grinding through a mixed stretch in the market, with the stock slipping over the past 3 months even as revenue and earnings continue to grow year over year. See ...

Zimmer Biomet Holdings (ZBH) has been drifting lower recently, with the stock down about 10% over the past 3 months and roughly 14% over the past year despite steady revenue and earnings growth. See ...

Zimmer Biomet (ZBH) could be a strong choice for your investment portfolio, due to its high cash yield, solid fundamentals, and discounted valuation. Companies like this have the capacity to leverage ...

In the eyes of one medtech executive, the most impressive innovation in the field over the past couple of years “comes down to connection.” In the past, medical device companies operated in silos, ...

Zimmer Biomet (ZBH) stock ought to be on your radar. Here's why – it is presently trading within the support range ($83.17 – $91.93), levels from which it has rebounded significantly in the past. Over ...

Zimmer Biomet Holdings Inc. (NYSE:ZBH) ranks among the best medical device stocks to invest in. Zimmer Biomet Holdings Inc. (NYSE:ZBH) announced on October 7 that it successfully acquired Monogram ...

Zimmer Biomet has completed its $177 million acquisition of Monogram Technologies, an orthopedic robotics company. The acquisition expands Zimmer’s suite of orthopedic robotics by adding Monogram’s ...

The first punch has been thrown in what’s shaping up to be a brawl between two well-respected global companies, one of them headquartered in northeast Indiana. A $69 million contract between Zimmer ...

Zimmer Biomet Holdings, Inc. has announced its acquisition of Monogram Technologies Inc. for $4.04 per share in cash, totaling approximately $177 million in equity value. This acquisition will create ...

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) on Monday agreed to acquire Monogram Technologies Inc. (NASDAQ:MGRM) for an upfront payment of $4.04 per share, corresponding to an equity value of ...